4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Bachem Holding AG (BANB) operates in the Biotechnology industry and is headquartered in Bubendorf, Switzerland with about 2,725 employees. Its market capitalization is roughly CHF 6 billion. In the fiscal year ended 2025-12-31, BANB reported CHF 695M in revenue and CHF 149M in net income.
Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | CHF 695M | CHF 605M | CHF 577M | CHF 532M | — |
| Gross Profit | CHF 200M | CHF 183M | CHF 177M | CHF 171M | — |
| Operating Income (EBIT) | CHF 167M | CHF 133M | CHF 129M | CHF 127M | — |
| Net Income | CHF 149M | CHF 120M | CHF 112M | CHF 101M | — |
CHF; CHFM / CHFB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | (CHF 31M) | (CHF 60M) | (CHF 56M) | (CHF 52M) | — |
CHF; CHFM / CHFB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | CHF 2.1B | CHF 1.9B | CHF 1.7B | CHF 1.4B | — |
| Total Liabilities | CHF 650M | CHF 532M | CHF 362M | CHF 214M | — |
CHF; CHFM / CHFB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive BANB viewer.
About TickerBase · Data methodology & sources · Privacy · Terms